Skip to main content
Top
Published in: Health and Quality of Life Outcomes 1/2005

Open Access 01-12-2005 | Research

Modification of the asthma quality of life questionnaire (standardised) for patients 12 years and older

Authors: Elizabeth F Juniper, Klas Svensson, Ann-Christin Mörk, Elisabeth Ståhl

Published in: Health and Quality of Life Outcomes | Issue 1/2005

Login to get access

Abstract

Background

The age limit for some adult asthma clinical trials has recently been lowered to 12 years. In this study we have made minor modifications to the standardised version of the adult Asthma Quality of Life Questionnaire (AQLQ(S)) to make it valid for patients 12 years and older (AQLQ12+).

Methods

We have used two clinical trial databases, in which the AQLQ12+ was used, to compare the measurement properties of the questionnaire in patients 12–17 years and patients 18 years and older. A total of 2433 patients (12–75 years), with current asthma and with data that could be evaluated both at randomisation and end of treatment, were included.

Results

The analysis showed that internal consistency, responsiveness and correlations with other clinical indices were very similar in patients 12–17 years and patients 18 years and older.

Conclusion

The measurement properties of the AQLQ12+ are similar in adolescents and adults and therefore the instrument is valid for use in adult studies which include children 12 years and older.
Literature
1.
go back to reference Juniper EF, Guyatt GH, Epstein RS, Ferrie PJ, Jaeschke R, Hiller TK: Evaluation of impairment of health-related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax 1992, 47: 76–83.PubMedCentralPubMedCrossRef Juniper EF, Guyatt GH, Epstein RS, Ferrie PJ, Jaeschke R, Hiller TK: Evaluation of impairment of health-related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax 1992, 47: 76–83.PubMedCentralPubMedCrossRef
2.
go back to reference Juniper EF, Guyatt GH, Feeny DH, Ferrie PJ, Griffith LE, Townsend M: Measuring quality of life in children with asthma. Qual Life Res 1996, 5: 35–46. 10.1007/BF00435967PubMedCrossRef Juniper EF, Guyatt GH, Feeny DH, Ferrie PJ, Griffith LE, Townsend M: Measuring quality of life in children with asthma. Qual Life Res 1996, 5: 35–46. 10.1007/BF00435967PubMedCrossRef
3.
go back to reference Juniper EF, Buist AS, Cox FM, Ferrie PJ, King DR: Validation of a standardized version of the Asthma Quality of Life Questionnaire. Chest 1999, 115: 1265–1270. 10.1378/chest.115.5.1265PubMedCrossRef Juniper EF, Buist AS, Cox FM, Ferrie PJ, King DR: Validation of a standardized version of the Asthma Quality of Life Questionnaire. Chest 1999, 115: 1265–1270. 10.1378/chest.115.5.1265PubMedCrossRef
4.
go back to reference Scicchitano R, Aalbers R, Ukena D, Manjara A, Fouquert L, Centanni S, Boulet LP, Naya IP, Hultquist C: Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma. Curr Med Res Opin 2004, 20: 1403–1418. 10.1185/030079904X2051PubMedCrossRef Scicchitano R, Aalbers R, Ukena D, Manjara A, Fouquert L, Centanni S, Boulet LP, Naya IP, Hultquist C: Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma. Curr Med Res Opin 2004, 20: 1403–1418. 10.1185/030079904X2051PubMedCrossRef
5.
go back to reference Morice AH, Osmanliev D, Arheden L, Beckman O: Therapeutic equivalence of a novel budesonide/formoterol pMDI versus budesonide/formoterol Turbuhaler(R) in adolescents and adults with asthma. J Allergy Clin Immunol 2005, 115: S2. Abs 8 10.1016/j.jaci.2004.12.025CrossRef Morice AH, Osmanliev D, Arheden L, Beckman O: Therapeutic equivalence of a novel budesonide/formoterol pMDI versus budesonide/formoterol Turbuhaler(R) in adolescents and adults with asthma. J Allergy Clin Immunol 2005, 115: S2. Abs 8 10.1016/j.jaci.2004.12.025CrossRef
6.
go back to reference Morice AH, Kukova Z, Arheden L, Beckman O: The novel budesonide/formoterol pMDI is therapeutically equivalent to budesonide/formoterol Turbuhaler(R) in children with asthma. J Allergy Clin Immunol 2005, 115: S209. Abs 833 10.1016/j.jaci.2004.12.846CrossRef Morice AH, Kukova Z, Arheden L, Beckman O: The novel budesonide/formoterol pMDI is therapeutically equivalent to budesonide/formoterol Turbuhaler(R) in children with asthma. J Allergy Clin Immunol 2005, 115: S209. Abs 833 10.1016/j.jaci.2004.12.846CrossRef
7.
go back to reference Juniper EF, Guyatt GH, Ferrie PJ, Griffith LE: Measuring quality of life in asthma. Am Rev Respir Dis 1993, 147: 832–838.PubMedCrossRef Juniper EF, Guyatt GH, Ferrie PJ, Griffith LE: Measuring quality of life in asthma. Am Rev Respir Dis 1993, 147: 832–838.PubMedCrossRef
8.
go back to reference Sanjuas C, Alonso J, Sanchis J, Casan P, Broquetas JM, Ferrie PJ, Juniper EF, Anto JM: The quality of life questionnaire with asthma patients; the Spanish version of the Asthma Quality of Life Questionnaire. Arch Bronconeumol 1995, 31: 219–226.PubMedCrossRef Sanjuas C, Alonso J, Sanchis J, Casan P, Broquetas JM, Ferrie PJ, Juniper EF, Anto JM: The quality of life questionnaire with asthma patients; the Spanish version of the Asthma Quality of Life Questionnaire. Arch Bronconeumol 1995, 31: 219–226.PubMedCrossRef
9.
go back to reference Leidy NK, Coughlin C: Psychometric performance of the Asthma Quality of Life Questionnaire in a US sample. Qual Life Res 1998, 7: 127–134. 10.1023/A:1008853325724PubMedCrossRef Leidy NK, Coughlin C: Psychometric performance of the Asthma Quality of Life Questionnaire in a US sample. Qual Life Res 1998, 7: 127–134. 10.1023/A:1008853325724PubMedCrossRef
10.
go back to reference Rutten-van Molken MPMH, Clusters F, Van Doorslaer EKA, Jansen CCM, Heurman L, Maesen FPV, Smeets JJ, Bommer AM, Raaijmakers JAM: Comparison of performance of four instruments in evaluating the effects of salmeterol on asthma quality of life. Eur Respir J 1995, 8: 888–898.PubMed Rutten-van Molken MPMH, Clusters F, Van Doorslaer EKA, Jansen CCM, Heurman L, Maesen FPV, Smeets JJ, Bommer AM, Raaijmakers JAM: Comparison of performance of four instruments in evaluating the effects of salmeterol on asthma quality of life. Eur Respir J 1995, 8: 888–898.PubMed
11.
go back to reference Juniper EF, Norman GR, Cox FM, Roberts JN: Comparison of the standard gamble, rating scale, AQLQ and SF-36 for measuring quality of life in asthma. Eur Respir J 2001, 18: 38–44. 10.1183/09031936.01.00088301PubMedCrossRef Juniper EF, Norman GR, Cox FM, Roberts JN: Comparison of the standard gamble, rating scale, AQLQ and SF-36 for measuring quality of life in asthma. Eur Respir J 2001, 18: 38–44. 10.1183/09031936.01.00088301PubMedCrossRef
12.
go back to reference Juniper EF, Guyatt GH, Willan A, Griffith LE: Determining a minimal important change in a disease-specific quality of life instrument. J Clin Epidemiol 1994, 47: 81–87. 10.1016/0895-4356(94)90036-1PubMedCrossRef Juniper EF, Guyatt GH, Willan A, Griffith LE: Determining a minimal important change in a disease-specific quality of life instrument. J Clin Epidemiol 1994, 47: 81–87. 10.1016/0895-4356(94)90036-1PubMedCrossRef
Metadata
Title
Modification of the asthma quality of life questionnaire (standardised) for patients 12 years and older
Authors
Elizabeth F Juniper
Klas Svensson
Ann-Christin Mörk
Elisabeth Ståhl
Publication date
01-12-2005
Publisher
BioMed Central
Published in
Health and Quality of Life Outcomes / Issue 1/2005
Electronic ISSN: 1477-7525
DOI
https://doi.org/10.1186/1477-7525-3-58

Other articles of this Issue 1/2005

Health and Quality of Life Outcomes 1/2005 Go to the issue